Shawn P. Foley

Partner | Co-Chair, Life Sciences

overview

Since joining Burns & Levinson in 2016, Shawn Foley has been immersed in pharmaceuticals and life sciences, with two areas of focus. First, he and his team conduct due diligence and freedom to operate studies for pharma companies, guiding them through a fast-growing maze of patents. Relevant technologies include small molecules and a variety of biologics such as therapeutic nucleic acids (mRNAs, RNA replicons, circular RNAs, and siRNAs); lipid-based delivery systems (LNPs and liposomes); CAR-T cells; macrophages; and bacterial and viral vaccines, including vaccines for COVID-19. Second, he and his team devise and implement global strategies for preparing and prosecuting patent applications in diverse technology areas, notably small molecule inhibitors; bifunctional degraders (PROTACs); viral vaccines; CAR-T and related adoptive cell transfer-based therapies; therapeutic antibodies and antibody-drug conjugates; cardiovascular drugs; personal care compositions; and fuel-based compositions, as well as diagnostic assays (e.g., detection of COVID-19, cell-free nucleic acid, and T cell activation).

Read More

education

J.D., George Mason University School of Law

B.A., Biochemistry, University of Pennsylvania

admissions

Massachusetts

New Jersey

North Carolina

honors & awards

Go To Intellectual Property Lawyer, Massachusetts Lawyers Weekly (2023)

IAM Patent 1000 – World’s Leading Patent Prosecution Professionals (2015)

Chambers USA: America’s Leading Lawyers for Business – Intellectual Property Law (2011)

speaking engagements

“IP Considerations for Startups”, Speaker, RESI Conference, September 2023

“IP Considerations for Startups – Navigating to Success”, Speaker, RESI Conference, March 2023

“Startups – Tips for Navigating your Company to Success,” Speaker, The Boston Entrepreneurs’ Network, Annual Meeting, December 2019

“CAR T – A Chronological Survey – From Whence it Came, Alternative Patenting Strategies, and Distinctions between Patentability and Commercialization,” Speaker, CAR-TCR Summit 2019, Boston Sept. 2019

“CAR T – A Chronological Survey – From Whence it Came, Alternative Patenting Strategies, and Distinctions between Patentability and Commercialization,” Speaker, CAR-TCR Summit Asia, June 2019 (Nominated for Top Speaker)

“Prolific Principal Investigators,” Moderator, Massachusetts Life Sciences Innovation Day, June 2019

“Startups – Tips for Navigating your Company to Success,” Speaker, The Boston Entrepreneurs’ Network, Annual Meeting, December 2018

“CAR-TCR Commercialization Track,” Moderator, CAR-TCR Summit 2018, September 2018

“IP and Licensing: Navigating the Landscape,” Speaker, CAR-TCR Summit 2018, September 2018

“Start-up Companies Pitch,” Moderator, Massachusetts Life Sciences Innovation Day, May 2018

“IP and Licensing: Navigating the Landscape,” Speaker, 8th Annual World Bispecific Summit, September 2017

“IP and Licensing: Navigating the Landscape,” Speaker, CAR-TCR Summit 2017, September 2017

“Looking Back – Entrepreneurial Voyages by Prior MALSI Inventors”, Moderator, Massachusetts Life Sciences Innovation Day, June 2017